This study addresses the usefulness of matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) MS for reliable identification of the two most frequently occurring clinical species of Rhizopus, namely Rhizopus arrhizus with its two varieties, arrhizus and delemar, and Rhizopus microsporus. The test-set comprised 38 isolates of clinical and environmental origin previously identified by internal transcribed spacer (ITS) sequencing of rDNA. Multi-locus sequence data targeting three gene markers (ITS, ACT, TEF ) showed two monophylic clades for Rhizopus arrhizus and Rhizopus microsporus (bootstrap values of 99 %). Cluster analysis confirmed the presence of two distinct clades within Rhizopus arrhizus representing its varieties arrhizus and delemar. The MALDI Biotyper 3.0 Microflex LT platform (Bruker Daltonics) was used to confirm the distinction between Rhizopus arrhizus and Rhizopus microsporus and the presence of two varieties within the species Rhizopus arrhizus. An in-house database of 30 reference main spectra (MSPs) was initially tested for correctness using commercially available databases of Bruker Daltonics. By challenging the database with the same strains of which an in-house database was created, automatic identification runs confirmed that MALDI-TOF MS is able to recognize the strains at the variety level. Based on principal component analysis, two MSP dendrograms were created and showed concordance with the multi-locus tree; thus, MALDI-TOF MS is a useful tool for diagnostics of mucoralean species.
INTRODUCTION
Rhizopus is a genus of the order Mucorales, family Rhizopodaceae, members of which are commonly present in indoor environments where they occupy habitats in early stages of organic matter decay (Dolatabadi, 2015) . Several species are spoilage agents of fresh and manufactured food (Hesseltine, 1983; Jennessen et al., 2005) , but they are also commonly applied in food fermentation of oriental foods, such as tempe, sufu, koji and ragi (Nout & Rombouts, 1990; Hesseltine, 1983; Jennessen et al., 2005) . Rhizopus species have also numerous biotechnological applications in the production of enzymes (e.g. lipases, amylases) and secondary metabolites (e.g. fumarate, malate and lactic acid) (Abe et al., 2007; Gosh & Ray, 2011) . On the other hand they are spoilage organisms of fruits and vegetables.
Rhizopus species comprise aetiological agents of mucormycosis, an acute fungal infection with high morbidity and mortality in patients with severe underlying metabolic or immune disorders, such as stem cell/solid organ transplants, diabetic mellitus, ketoacidosis, increased serum iron, neutropenia, haematologic malignancies or birth prematurity (Skiada et al., 2011; Lanternier et al., 2012; Roilides et al., 2012; Chowdhary et al., 2014) . The disease is angioinvasive, leading to thrombosis and extended necrosis, and is rapidly progressive with high rates of mortality (w50%), that approach 100% among patients with disseminated disease or those with persistent neutropenia. Clinical manifestation of the disease occurs as rhinocerebral, pulmonary, gastrointestinal, renal or disseminated infection (Ibrahim et al., 2012) . The number of cases is increasing, especially in patients with impaired immunity due to e.g. organ transplantation. Rhizopus arrhizus (previously known as Rhizopus oryzae) is the prime species responsible for 70% of all cases of mucormycosis and 90% of rhinocerebral cases, while Rhizopus microsporus is the third most frequent opportunist in the Mucorales with 15-25% of cases worldwide (Roden et al., 2005) . Thus, the genus Rhizopus is the most important clinical entity involved in mucoralean infections (Skiada et al., 2011; Lanternier et al., 2012; Rammaert et al., 2012; Roilides et al., 2012; . Thus far, diagnostic methods have focused mostly on Lichtheimia and partly Mucor species, which are the second most common aetiological agents of mucormycosis in Europe and the USA (Skiada et al., 2011; Schrödl et al., 2012) , and studies related to Rhizopus have remained neglected.
Treatment of mucormycosis is based on antifungal therapy combined with surgery, using amphotericin B as a prime drug. The choice of antifungal agents used differs widely between various mucoralean fungi at species or even variety level; e.g. amphotericin B shows different activities against Rhizopus microsporus and Rhizopus arrhizus, thus confirming different susceptibility patterns between species or even varieties of mucoralean fungi (Chowdhary et al., 2014; Caramalho et al., 2015) .
Currently, reliable identification of Mucorales species remains challenging for many laboratories as it relies on microscopy and molecular methods. Reliable identification of clinical isolates at the species level is challenging and time consuming in many routine laboratories, which makes the choice of optimal treatment difficult (Ibrahim et al., 2008; Lamaris et al., 2009; Lass-Flörl, 2009 ). Culturing mucoralean species from patient material may also be difficult because of lack of sporulation in tissue and the coenocytic structure of the mycelium. Histopathological observation remains inconclusive for species or even generic identification, which is essential for optimal antifungal therapy selection (Griffin & Hanson, 2014) . DNA-based methods, such as internal transcribed spacer (ITS) sequencing, are time-consuming and require several preparatory steps (e.g. DNA extraction, gene PCR amplification and data analysis). Some agents of mucormycosis have a rather high intraspecific molecular variability, as the ITS of the rDNA may vary up to 3.24%, which is in contrast to 1.96% as a maximum molecular variability in ascomycetous species (Nilsson et al., 2008) , and this is also reflected in their diverse antifungal susceptibility even at variety level (e.g. posaconazole MIC range) (Chowdhary et al., 2014) . Machouart-Dubach et al. (2001) introduced RFLP as a rapid method for the separation of the main species of Mucorales, but this technique requires availability of a set of specific primers. No serological indicator for mucormycosis is available at this moment (Griffin & Hanson, 2014) . Considering the difficulties in early diagnostics, time needed for identification, the acute invasive infection type, and a steady increase in the number of cases, the availability of reproducible and rapid species recognition are essential to decrease mortality rates due to this infection.
Here we present the application of matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) MS for the identification of the most important clinical species of Rhizopus, viz. Rhizopus microsporus and Rhizopus arrhizus, with its two varieties, var. arrhizus and var. delemar (Dolatabadi et al., 2014a) . The data generated by multilocus sequence typing (MLST) was compared with those from MALDI-TOF MS for correct species differentiation. The accuracy of MALDI-TOF MS results was compared with those from the four clinically relevant genera of Mucorales, including the type species of Rhizopus, Rhizopus stolonifer.
METHODS
Strains and cultivation. Thirty nine reference and type strains from Fungal Biodiversity Centre (CBS-KNAW), Utrecht, the Netherlands were used (Table 1) . These included 26 strains of Rhizopus arrhizus with 13 strains of Rhizopus arrhizus var. arrhizus and 13 strains of Rhizopus arrhizus var. delemar, and 13 strains of Rhizopus microsporus. For preservation, serial transfer and DNA isolation, strains were cultured on 5% malt extract agar (MEA; Oxoid) in 8 cm diameter culture plates and incubated for 72 h at 30 uC.
Multi-locus sequencing. DNA extraction and PCR conditions were followed according to methods described previously (Dolatabadi et al., 2014b) . Markers included the rDNA ITS region, and parts of the actin (ACT) and translation elongation factor 1-a (TEF) genes. Consensus sequences were reconstructed by means of SeqMan v. 9.0.4 (DNASTAR). Sequences of each marker were aligned in MEGA5 of the Lasergene software package (DNASTAR) using CLUSTAL W. Concatenated sequences were imported to MEGA5 for the reconstruction of a final MLST tree using maximum-likelihood. The optimal substitution model (T92+G+I, Tamura 3) was selected by MEGA5. Robustness of tree topology was estimated by bootstrapping with 1000 replicates. The final tree was drawn in Adobe Illustrator Artwork 15.1.
MALDI-TOF MS sample preparation. A protocol of standardized liquid cultivation with constant rotation, developed for cultivation of filamentous fungi and used for the construction of the Filamentous Fungi v. 1 Library by Bruker Daltonics (Bremen, Germany) was followed. Falcon tubes (15 ml) containing 7 ml Sabouraud dextrose broth (Difco) were inoculated and incubated on a tube rotator SB2 (Stuart) (20 r.p.m.) at room temperature for 24-72 h followed by centrifugation (1 min, 3000 r.p.m.). An aliquot (1.5 ml) of the fungal biomass sediment was transferred to Eppendorf tubes and 1 ml sterile NA, Not available; CBS, Centraalbureau voor Schimmelcultures Fungal Biodiversity Centre, Utrecht, The Netherlands; T, type strain of (synonymized) taxonomic entity; Auth, authentic strain for a taxonomic entity. AA, AB: Rhizopus arrhizus var. arrhizus strains (lactic acid producers) based on the classification by Abe et al. (2007) . DD, DC: Rhizopus arrhizus var. delemar strains (fumaricmalic acid producers) based on the classification by Abe et al. (2007) . GenBank accession numbers are provided.
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MilliQ water was added to the pellet followed by vortexing. A washing step was performed three times. The final supernatant was removed and 1.2 ml 70% ethanol was added.
A crude protein extraction protocol using the formic acid/ethanol sample preparation method (Bruker Daltonics) was followed (Marklein et al., 2009; Kolecka et al., 2013) . The samples were centrifuged (3 min, 14 000 r.p.m.), the supernatant was removed and the pellets were air-dried in a laminar flow cabinet for 30 min. The pellets were firstly dissolved in 25-40 ml 70% formic acid (Sigma-Aldrich), depending on the pellet size, and, after vortexing, an equal volume of 100% acetonitrile (Fluka) was added and mixed. Samples were then centrifuged (14 000 r.p.m., 2 min) and supernatants were immediately used to generate reference mass spectra.
MALDI-TOF MS in-house library and identification. Mass spectra were generated with a MALDI Biotyper 3.0 Microflex LT platform (Bruker Daltonics). From 38 strains with 25 strains representing R. arrhizus and 13 R. microsporus an in-house database was created. For each strain, 1 ml of crude protein extract was deposited on eight spots of a 96-spot polished steel target plate (Bruker Daltonics), air-dried and covered with 1 ml HCCA matrix solution (Bruker Daltonics) (Kolecka et al., 2013) . As a positive control and calibration reference, 1 ml Bacterial Test Standard (BTS; Bruker Daltonics) was used. The main spectrum (MSP) was acquired from 24 individual spectra generated per isolate using the MALDI Biotyper automated Flex Control software v. 3.0 (Bruker Daltonics). A minimum of 20 individual, high-quality spectra were selected with Flex Analysis software v. 3.3 (Bruker Daltonics) to create the respective MSPs to be stored as an in-house database entry. Comparison of the MSPs was performed by principal component analysis (PCA) resulting in a distance score oriented dendrogram (Fig. 1) . The identification of the isolates, each represented by an MSP, was tested in silico using MALDI Biotyper 3.0 RTC software (Bruker Daltonics) with the two Bruker Daltonics commercial databases simultaneously, namely BDAL database (4110 MSPs) and Filamentous Fungi v. 1 Library and the inhouse Rhizopus library.
RESULTS
Multi-locus sequencing
The set of 39 strains studied included the type strains of Rhizopus microsporus and the two varieties of Rhizopus arrhizus and their synonyms from clinical, environmental and food-associated sources obtained from diverse geographical origins. Sequences were generated targeting three gene markers (ITS, ACT, TEF) and concatenated sequences were used to generate the tree. A maximum-likelihood phylogenetic tree confirmed the correct concepts of the Rhizopus species and their separation in accordance with literature data (Fig. 1) . The multi-locus tree showed separation of two main clades, supported by a bootstrap value of 99% for Rhizopus microsporus and Rhizopus arrhizus. In Rhizopus arrhizus separation of the two varieties was observed but this was only supported a by bootstrap value of 47% due to high sequence similarity between the varieties. Phylogenetic analysis proved monophyly for each species, which was concordant with data shown previously (Dolatabadi et al., 2014a, b) and was considered as proof of correct identification of strains to be used in the MALDI-TOF MS experiment. Sequences generated for the analysis are deposited in GenBank (Dolatabadi et al., 2014a, b) .
MALDI-TOF MS
The MSPs were automatically classified and identified using MALDI Biotyper 3.0 software. The CBS in-house Rhizopus library was created with 38 MSPs out of 39 Rhizopus strains (Table 1) . Strain CBS 264.28 was excluded from the further MALDI-TOF MS analyses as after two unsuccessful attempts, this isolate did not show sufficient growth in liquid media, although robust growth on solid media was confirmed (Fig. 1) .
The mass spectra of the relevant type strains (i.e. CBS 699.68 NT , CBS 120.12 T and CBS 112.07 T in Table 1 ) were unique for the two species and the two varieties enabling reliable separation (data not shown). Identification results with the set tested confirmed correct identity for all MSPs at species level and no false-positive results were observed. Discrimination of Rhizopus isolates at species and variety levels was later confirmed as shown in the MSP dendrogram generated using the PCA application of MALDI Biotyper 3.0 software (Fig. 1) .
The results of the above set of 38 strains were supplemented with MSPs from the Filamentous Fungi v. 1 Library including the four mucoralean genera Rhizopus, Mucor, Rhizomucor and Lichtheimia to show unambiguous separation of all species (Fig. 2) . Thirty-five MSPs from these four clinically relevant genera were selected from the commercial Bruker Filamentous Fungi v. 1 Library, viz. Rhizopus (16 MSPs), Mucor (6 MSPs), Rhizomucor (2 MSPs) and Lichtheimia (11 MSPs) (Fig. 2) . The topology of the extended PCA dendrogram showed a clustering similar to the MLST phylogeny and supported the separation of the varieties arrhizus and delemar of Rhizopus arrhizus.
DISCUSSION
MALDI-TOF MS has primarily been used for identification of bacteria and yeasts, and is increasingly applied in identification of filamentous fungi such as Fusarium, Aspergillus, Penicillium and Ramularia (Alanio et al., 2011; Bader et al., 2011; Hettick et al., 2008; De Carolis et al., 2012; Videira et al., 2015) . In the basal lineages of the fungal kingdom, a comprehensive report on MALDI-TOF MS identification of Lichtheimia species has appeared (Schrödl et al., 2012) . Other studies investigated more diverse sets of strains, but the number of mucoralean fungi was either limited or not the focus of the study and lacked comparison with the phylogeny of the fungi (De Carolis et al., 2012; Becker et al., 2014; Ranque et al., 2014) .
Rhizopus microsporus and Rhizopus arrhizus (including both varieties) do not show significant differences in their physiological profiles of growth temperature, nitrogen and carbon assimilation, and enzyme production (Dolatabadi et al., 2014a, b) . The two varieties of Rhizopus arrhizus, MALDI-TOF MS of Rhizopus species however, differ in the production of fumaric-malic (var. delemar) or lactic acid (var. arrhizus) (Abe et al., 2007) . Size, shape and ornamentation of spores, which have been used in the past for species and variety distinction, remained inadequate for differentiation of these taxa (Dolatabadi et al., 2014a, b) .
Virulence of Rhizopus strains was shown to be independent from the source of isolation of the respective strains (Kaerger et al., 2015) . Within Mucorales and between Rhizopus species, significant differences in antifungal susceptibility were observed (Vitale et al., 2012) . Therefore, identification of clinical isolates at species level is helpful to decide on appropriate antifungal therapy based on known susceptibility profiles of the species. Rhizopus arrhizus has a high MIC range for AmB followed by Rhizopus microsporus among Fig. 1 . Cluster analysis of 38 MALDI-TOF main MSPs of strains belonging to Rhizopus species that were used to create the CBS-KNAW in-house database. Distance level of subdivision is displayed in arbitrary units. Bar, 0.05 substitutions per site. Bootstrap values (percentages of 1000 replicates) are shown at nodes. These strains were validated by sequencing of the ITS, ACT and TEF gene markers presented in an MLST tree. T, type strain, NT, neotype, Auth, authentic strain. Grey bars, Rhizopus microsporus; dashed bars, Rhizopus arrhizus var. arrhizus; white bars, Rhizopus arrhizus var. delemar.
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other members of the Mucorales, which could be due to the ignorance regarding the two varieties in the past (Caramalho et al., 2015) .
Within both Rhizopus species studied, several varieties have been described in older literature, but recent molecular studies considered Rhizopus microsporus to be monophyletic and within Rhizopus arrhizus two varieties were maintained (Dolatabadi et al., 2014a, b) . Three type strains of former varieties, i.e. varieties microsporus, azygosporus and chinensis were included in the set of strains analysed and were found randomly distributed within the Rhizopus microsporus cluster in the MALDI-TOF MS dendrogram and the multi-locus tree, thus confirming that they belong to one species (Fig. 1) . Two strains of Rhizopus microsporus, CBS 700.68 and CBS 699.68 NT , both isolated from soil, occurred at an external position in the multilocus analysis (Dolatabadi et al., 2014b) and were also among the deviating strains in the MALDI-TOF MS dendrogram (Fig. 1) . The two varieties of Rhizopus arrhizus can be identified by ITS sequence data (Dolatabadi et al., 2014a) , having a maximum of 5 bp difference, and phenotypically they can be distinguished by either fumaric-malic acid or lactic acid production (Abe et al., 2007) . Singlelocus trees based on ITS, TEF and ACT were concordant (Dolatabadi et al., 2014b) . The differences between the varieties were also observed with amplified fragment length polymorphism profiling (Chowdhary et al., 2014; Dolatabadi et al., 2014b) , and with MALDI-TOF MS these two groups could be discerned and the result was concordant with the MLST tree (Fig. 1) . These results show that MALDI-TOF MS may contribute to the clarifying of the taxonomy of these filamentous fungi.
Considering the increasing number of fungal infections, MALDI-TOF MS provides fast identification in the routine clinical laboratory. As with most molecular methods, interspecies distances in Mucorales tend to be quite high (3.24%) compared with the observed intraspecific variation, leading to a considerable barcoding gap despite 
MALDI-TOF MS of Rhizopus species
high intraspecific variability, which enhances reliable species differentiation (Walther et al., 2013) . This is also expressed in the results obtained by MALDI-TOF MS and MLST analysis where overlap between species was negligible.
Compared with the molecular methods of identification which require culturing, DNA extraction, PCR and sequencing, MALDI-TOF MS has a shorter period of extraction and PCR and sequencing steps are omitted. So the process can be easily shortened to 2 days.
MALDI-TOF MS has been implemented as a rapid, simple and cost-effective high-throughput proteomic technique that yielded correct identification at the species and variety levels for 38 strains of Rhizopus. The addition of further clinical and environmental strains from four genera from the Flamentous Fungi v. 1 Library showed that the identification potential of MALDI-TOF MS in Mucorales covers a wide range of infective mucoralean species. However, the availability of a reliable database based on a well-resolved taxonomy using molecular data is needed to allow correct identification of isolates, as was considered exemplarily in our study.
